Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
P.A. van der Ley, Afshin Zariri, Elly van Riet, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

The roles of extracellular vesicles in the immune system
Edit I. Buzás
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 236-250
Open Access | Times Cited: 718
A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants
Linglei Jiang, Tom A. P. Driedonks, Wouter S. P. Jong, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 119
Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 24
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 2
Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy
Qiong Long, Peng Zheng, Xiao Zheng, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114321-114321
Closed Access | Times Cited: 65
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Biological Nanoparticles in Vaccine Development
Stephanie M. Curley, David Putnam
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 45
Outer membrane vesicles: A bacterial-derived vaccination system
Linda A. Lieberman
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 39
The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants
Nathaly Vasquez-Martínez, Daniel Guillén, Silvia Moreno-Mendieta, et al.
Polymers (2023) Vol. 15, Iss. 7, pp. 1615-1615
Open Access | Times Cited: 25
The unfulfilled potential of mucosal immunization
James R. Baker, Mohammad Farazuddin, Pamela T. Wong, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 1, pp. 1-11
Open Access | Times Cited: 37
Outer Membrane Vesicle Vaccine Platforms
Francesca Micoli, Roberto Adamo, Usman Nakakana
BioDrugs (2023) Vol. 38, Iss. 1, pp. 47-59
Open Access | Times Cited: 23
Role of Bacterial Extracellular Vesicles in Manipulating Infection
Guanqi Zhao, Melissa K. Jones
Infection and Immunity (2023) Vol. 91, Iss. 5
Open Access | Times Cited: 20
The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
Amirhosein Faghihkhorasani, Hanan Hassan Ahmed, Noor Muhammad Mashool, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
The Bacterial Spore as a Mucosal Vaccine Delivery System
Anella Saggese, Loredana Baccigalupi, Giuliana Donadio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10880-10880
Open Access | Times Cited: 17
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
Kairat Tabynov, Maxim Solomadin, Nurkeldi Turebekov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential
Ming Yao Ho, Songhan Liu, Bengang Xing
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges
Ziyi Bai, Dandan Wan, Tianxia Lan, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24650-24681
Open Access | Times Cited: 7
Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
Dennis Christensen, Charlotta Polacek, Daniel J. Sheward, et al.
EBioMedicine (2022) Vol. 84, pp. 104248-104248
Open Access | Times Cited: 27
Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine
Jian Hang Lam, Devendra Shivhare, Teck Wan Chia, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 16757-16775
Open Access | Times Cited: 24
Physical Health and Mental Fatigue Disability Associated with Long COVID: Baseline Results from a US Nationwide Cohort
Bryan Lau, Eryka Wentz, Zhanmo Ni, et al.
The American Journal of Medicine (2023)
Closed Access | Times Cited: 14
Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
Devanshi R. Patel, Allen M. Minns, Derek G. Sim, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 6
Mucosal vaccines for viral diseases: Status and prospects
Bingjie Ma, Mengxiao Tao, Zhili Li, et al.
Virology (2024) Vol. 593, pp. 110026-110026
Closed Access | Times Cited: 6
Tailoring biomaterials for vaccine delivery
Yanling Zhuo, Huanxuan Zeng, Chunyu Su, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses
Dung T. Huynh, Emanuele Nolfi, Lobna Medfai, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
Rick Heida, Henderik W. Frijlink, Wouter L.J. Hinrichs
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top